Rawan Hallal

Acriflavine targets oncogenic STAT5 signaling in myeloid leukemia cells

F. Gouilleux, F. Mazurier, K. Zibara, 2020, Journal of cellular and molecular medicine.

Repurposing of Acriflavine to target Chronic Myeloid Leukemia treatment.

F. Kobeissy, F. Gouilleux, F. Mazurier, 2020, Current medicinal chemistry.

Combination of Angiotensin (1-7) Agonists and Convalescent Plasma as a New Strategy to Overcome Angiotensin Converting Enzyme 2 (ACE2) Inhibition for the Treatment of COVID-19

F. Kobeissy, A. Eid, K. Zibara, 2021, Frontiers in Medicine.

DeSUMOylation of chromatin-bound proteins limits the rapid transcriptional reprogramming induced by daunorubicin in acute myeloid leukemias

J. Olsen, C. Andrieu-Soler, L. Vallar, 2023, Nucleic acids research.

SUMOylation inhibitor TAK-981 (subasumstat) synergizes with 5-azacytidine in preclinical models of acute myeloid leukemia

D. Tempé, M. Piechaczyk, G. Cartron, 2023, Haematologica.